Original language | English |
---|---|
Pages (from-to) | 1-2 |
Journal | The Lancet |
DOIs |
|
Publication status | Published - 29 Apr 2020 |
Remdesivir for COVID-19: challenges of underpowered studies
Research output: Contribution to journal › Comment/debate › peer-review
Research output: Contribution to journal › Comment/debate › peer-review
Original language | English |
---|---|
Pages (from-to) | 1-2 |
Journal | The Lancet |
DOIs |
|
Publication status | Published - 29 Apr 2020 |